Ubs Asset Management Americas Inc Astrazeneca PLC Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 183,548 shares of AZN stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,548

Holding current value

$13.9 Million

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $11.6 Million - $14.6 Million	183,548 New	183,548 $12 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $12.3 Million - $13.9 Million	194,200 New	194,200 $13.5 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $2.8 Million - $7.17 Million	-52,800 Reduced 19.04%	224,500 $12.3 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $15 Million - $18 Million	253,185 Added 1049.91%	277,300 $18.3 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $1.34 Million - $1.47 Million	24,115 New	24,115 $1.45 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $263,039 - $312,599	-6,195 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $50,029 - $56,701	1,247 Added 25.2%	6,195 $276,000
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $16,440 - $18,380	441 Added 9.78%	4,948 $0
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $72,754 - $88,191	-2,050 Reduced 31.26%	4,507 $0
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $40,619 - $45,721	-1,102 Reduced 14.39%	6,557 $249,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $1,738 - $1,986	50 Added 0.66%	7,659 $0
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $246,859 - $264,722	7,145 Added 1539.87%	7,609 $0
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $6,824 - $7,582	-207 Reduced 30.85%	464 $0
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $7,669 - $8,312	239 Added 55.32%	671 $0
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $12,510 - $14,688	432	432 $0

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Astrazeneca PLC Transaction History